Haematologic Technologies is a large molecule CRO unlike any other. Combining world class protein chemistry expertise, integrated large molecule analytical services, and customized products to support biopharma R&D, we accelerate large molecule drug development for clients around the globe.
Here's what makes us different!Large Molecule Focus
- Plasma (Native) Protein and Antibody Therapeutics
- Recombinant Protein and Antibody Therapeutics (mAb's, Polyclonals)
- Antibody Drug Conjugates (ADC's)
- Cell and Gene Therapy
- Vaccines / Viral Vectors
Specific Therapeutic Areas of Expertise
- Rare Diseases: Hemophilia, Duchenne Muscular Dystrophy, Other rare genetic disorders
- Immuno-therapeutics: Hyperimmunes, IVIG, Allergy, Auto-immune disorders
- Oncology: Immuno-oncology, blood cancers
- Coagulation: Clotting/Bleeding Disorders; Therapeutics impacting on Hemostasis
- General: Expertise in a wide range of other therapeutic areas
